Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c522ca84-adec-4303-8da3-06a98ea62e9b&Preview=1 Date 1/10/2012 Company Name EveryMove Mailing Address 2607 2nd Avenue Seattle, WA 98121 Company Description We are a team of dedicated healthcare entrepreneurs and technologists who believe that by working together we can inspire each other to better health. We call this the EveryMove Movement and we want you to join … Continue reading “EveryMove Garners $375,000 New Financing”
Category: Seattle
TechStars Grad EveryMove Raises $375K
EveryMove, a member of the Seattle TechStars 2011 class, has filed regulatory paperwork for a $375,000 investment round. Investors weren’t disclosed, but BuddyTV founder Andy Liu and Premera BlueCross vice president Kent Marquardt were listed on the SEC form as directors (Liu also is listed as an executive). EveryMove is building a health-tracking software service … Continue reading “TechStars Grad EveryMove Raises $375K”
Lack of Funding For Innovative Biotech Companies
[Editor’s Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including “What would you be willing to throw a punch over?”] The most important issue facing Aastrom and many other companies in biotechnology is the lack of adequate funding to support innovative new companies, … Continue reading “Lack of Funding For Innovative Biotech Companies”
Young Entrepreneur Social: Seattle Has to Stop Eating its Young
Brayden Olson was frustrated. After a couple of years spent beating the bushes for successful young entrepreneurs in the Seattle area, the 24-year-old says he could only find a few people he considered peers. And even worse, Olson says, was the lack of generosity he found among the 30-something generation of Seattle entrepreneurs that came … Continue reading “Young Entrepreneur Social: Seattle Has to Stop Eating its Young”
Benefits and Roadblocks of Corporate Partnering for Startups
Fifteen years ago, the expansion model of a startup was fairly linear: The first three years were dedicated to building the business domestically. Year four generally saw European expansion. And by year five, the company was starting to explore the Asian markets. The emergence of the Web as a viable commerce vehicle, though, brought about … Continue reading “Benefits and Roadblocks of Corporate Partnering for Startups”
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Biotech pilgrims are gathering today for the biggest industry frenzy of the year, the JP Morgan Healthcare Conference. This confab in San Francisco’s Union Square is the singular place each year where essentially all industry mover/shakers—and many wannabes—gather for a marathon week of investment scouting, dealmaking, publicity seeking, job-hunting, and schmoozing. I’ve been going to … Continue reading “Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference”
Founder’s Co-Op Closes $8M Second Fund
Founder’s Co-op, the Seattle-based early stage investment group headed by Andy Sack and Chris DeVore, has closed its second fund at just under $8 million. That’s a significant step up from the first Founder’s Co-op fund, which DeVore says was about $2.5 million—a shift that reflects both the growth of Seattle’s startup scene, and a … Continue reading “Founder’s Co-Op Closes $8M Second Fund”
Seattle Rewind: Ozzie’s Startup, Mobile Predictions, Big Questions
We’re back in the swing of things after the holidays, which means this is your first weekly rewind of the new year. Read on, especially if you were too busy catching up on e-mails and meetings to pay attention to the Seattle-area headlines the first time around: —Former Microsoft software chief Ray Ozzie resurfaced this … Continue reading “Seattle Rewind: Ozzie’s Startup, Mobile Predictions, Big Questions”
Gathering Around the Tablet: A Glimpse of the Future
How will the media habits of families, especially those with young kids, evolve in the era of the tablet computer? I got an interesting perspective on that question over the holidays, which I spent with my brother and his family in Alaska. Jamie and his wife Jen Athey have two loveable children, aged four (Kieran) … Continue reading “Gathering Around the Tablet: A Glimpse of the Future”
Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor
Seattle-based Mirador Biomedical has won FDA clearance to market its medical device for a new set of uses, which doctors have been asking about for months. Mirador said today that its digital pressure sensor technology, which it calls its Compass platform, is now cleared by the FDA for a half dozen different medical uses. The … Continue reading “Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor”
RealNetworks CFO Stepping Down
RealNetworks, which recently installed a new CEO, is looking for a new financial chief. The company says CFO Michael Eggers is leaving effective April 15, via a filing with federal regulators (hat tip to John Cook at GeekWire for spotting). Eggers has been at RealNetworks (NASDAQ: [[ticker:RNWK]]) for 14 years, according to the SEC filing—quite … Continue reading “RealNetworks CFO Stepping Down”
Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up
[Updated 1:45 p.m. ET] Executive compensation held relatively steady in 2011 among privately-held life sciences companies, while their peers in the technology sector continued to see salary increases, according to the annual CompStudy survey produced by executive search firm J. Robert Scott and law firm WilmerHale in collaboration with Noam Wasserman, associate professor of business administration … Continue reading “Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up”
Ray Ozzie’s Next Big Thing: Cocomo
Since when is naming your startup and posting a job ad news? When your name is Ray Ozzie, that’s when. The former Microsoft chief software architect and Lotus veteran has surfaced after a year of working behind the scenes. Ozzie reached out to the Boston Globe‘s Scott Kirsner with a teaser about his new project: … Continue reading “Ray Ozzie’s Next Big Thing: Cocomo”
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms
[Update: 6:58 am PT] Dendreon greatly disappointed investors in 2011, but it ended up closing the year out on a stronger note than expected. The Seattle-based biotech company (NASDAQ: [[ticker:DNDN]]) said today it generated $82 million in fourth quarter gross product revenues for sipuleucel-T (Provenge), its immune-boosting therapy for prostate cancer. The company hasn’t yet … Continue reading “Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms”
Startup Weekend Shuts Down Eight-City Startup Foundation Project
Startup Weekend, the Seattle-based nonprofit that runs an international network of hackathon events, is shutting down its effort to create a sister organization called the Startup Foundation. That project, first reported by Xconomy back in June, aimed to create a more permanent presence in individual cities that could help stimulate the entrepreneurial community. When I … Continue reading “Startup Weekend Shuts Down Eight-City Startup Foundation Project”
JeNu Biosciences Secures $1,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da5f1079-cc59-4eeb-8446-471319882b1d&Preview=1 Date 1/5/2012 Company Name JeNu Biosciences Mailing Address 3911 Ne Belvoir Place Seattle, WA 98105 Company Description JeNu is looking to use ultrasound waves to deliver specially formulated creams into the skin, or simply, “put good things into the skin,”. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,500,000 Transaction Round … Continue reading “JeNu Biosciences Secures $1,500,000 New Funding”
Seattle Deals: Ubermind, iCopyright, Vizify
—Consulting firm Deloitte has acquired Seattle mobile developer Ubermind, the companies announced Wednesday. Terms of the deal weren’t disclosed. Ubermind CEO Shehryar Khan and founder Donald Brady will join Deloitte Consulting as principals, according to Deloitte’s press release. On its blog, Ubermind says that Deloitte’s large footprint is a big opportunity for the smaller company, … Continue reading “Seattle Deals: Ubermind, iCopyright, Vizify”
The Year Ahead for Cleantech Investing in the Pacific Northwest
Even though our local economy is far from strong, I am pleased to report that at the Northwest Energy Angels, we continue to see and invest in interesting deals across the spectrum of clean technologies. In the past year, we’ve seen and closed deals in virtually every segment of the cleantech industry, including more efficient … Continue reading “The Year Ahead for Cleantech Investing in the Pacific Northwest”
Loosen the Rules Stifling IPOs by Venture-Backed Startups
[Editor’s Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including “What would you be willing to throw a punch over?”] What would I be willing to throw a punch over? Solving the small-cap IPO bottleneck … to unleash the job creating potential of … Continue reading “Loosen the Rules Stifling IPOs by Venture-Backed Startups”
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan
Seattle-based Allozyne has made a small set of job cuts after it was unable to pull the trigger on its plan to go public late last year, Xconomy has learned. Allozyne has let go some of its scientific staff, according to a source close to the situation. When asked how many jobs were eliminated, and … Continue reading “Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan”
Amazon, Microsoft Expected to Make Waves in Mobile This Year
Mobile industry leaders are looking for big moves in 2012 from the Seattle area’s two technology heavyweights, taking the lead from a surge by Google’s Android operating system, according to a new survey from Issaquah, WA-based Chetan Sharma Consulting. Sharma’s 2012 Mobile Industry Predictions Survey, compiled from about 150 responses through the consulting firm’s global … Continue reading “Amazon, Microsoft Expected to Make Waves in Mobile This Year”
JeNu Biosciences Raises $1.5M for Ultrasound to “Put Good Things in Skin”
Seattle-based JeNu Biosciences has raised some new cash to go after the emerging market for ultrasound-based skin care devices. The company has pulled in $1.5 million from Seattle’s Second Avenue Partners and other angel investors, out of a round that is expected to be worth $3 million, says CEO Wayne Wager. JeNu has now raised … Continue reading “JeNu Biosciences Raises $1.5M for Ultrasound to “Put Good Things in Skin””
Diabetes Drugs Could Cure Cancer
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] Drugs for type 2 diabetes have the potential to become effective therapies for certain types of cancers. Tumor cells have increased energy needs, and starving them of … Continue reading “Diabetes Drugs Could Cure Cancer”
Counting Coups: Better, Fewer Deals in 2011 for Venture-Backed Cos.
2011 was a year of bigger deals and fewer exits for venture-backed companies, according to data being released today by Dow Jones VentureSource. VentureSource says that venture-backed companies netted $53.2 billion through a total of 522 deals of all kinds in 2011—mergers, buyouts, and IPOs. That was a 14 percent decline in the number of … Continue reading “Counting Coups: Better, Fewer Deals in 2011 for Venture-Backed Cos.”
Healthcare That Works
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] Reinventing the absolutely dysfunctional healthcare delivery system in the U.S. It is a daunting idea, as it requires major changes in 100 years worth of doctor and … Continue reading “Healthcare That Works”
All-Electric Transportation
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] All-electric commercial boats, ships, railway engines, and aircraft. The hyper-convergence of energy generation, battery storage, electric vehicle systems development, and electric charging infrastructure has first focused commercially … Continue reading “All-Electric Transportation”
Technology That Finally Helps Learning
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] That technology can actually play a significant positive role in education. The false promises go back at least 100 years—to extravagant claims by Thomas Edison. Certainly “computers … Continue reading “Technology That Finally Helps Learning”
Clear Catheter Systems Obtains $4,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8bd9957-b922-4480-8940-3ae6d9e49124&Preview=1 Date 12/30/2011 Company Name Clear Catheter Systems Mailing Address 20380 Halfway Road Bend, OR 97701 Company Description Clear Catheter Systems is a Bend, Oregon based medical device company pioneering new technologies that will revolutionize medical tube drainage. Website http://www.pleuraflow.com Transaction Type Venture Equity Transaction Amount $4,000,000 Transaction Round Series A Proceeds … Continue reading “Clear Catheter Systems Obtains $4,000,000 Series A Financing”
Scope 5 Lands New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4228d843-553f-49fe-bfa9-887666a5daf3&Preview=1 Date 12/30/2011 Company Name Scope 5 Mailing Address Undisclosed Seattle, WA 98100 Company Description Scope 5 is a maker of web-hosted software to manage environmental sustainability and energy data. Website http://www.scope5.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes Our investors moved briskly so that we can … Continue reading “Scope 5 Lands New Financing Round”
Alternative Online Payments: The Dream That Refuses to Die
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?” ] After nearly twenty years of failed attempts, I’m still a believer in the potential transformative power of the “crazy idea” of alternative Internet payment systems, particularly … Continue reading “Alternative Online Payments: The Dream That Refuses to Die”
Healthy Transgenic Foods
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Transgenic foods that are programmed and cultivated not so much to lower costs at the risk of ruining health and the environment, but the opposite—like a tomato that produces lots of Omega3 … Continue reading “Healthy Transgenic Foods”
Xconomy Seattle’s Top 12 Life Sciences Stories of the Year
It’s Editor’s Picks time at the end of the year, which is a sure sign that your local journalists are looking to stick something on the site you can read during a slow week so we can spend time with our families. Seriously, this has been a fascinating and typically frenzied year for us at … Continue reading “Xconomy Seattle’s Top 12 Life Sciences Stories of the Year”
Cure for Diabetes
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] If I can only pick one, I’d patent a functional cure for diabetes—whether it’s an artificial pancreas, a treatment to spare beta cells, or a means to prevent insulin resistance. However it … Continue reading “Cure for Diabetes”
Vizify Garners $940,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cd31ab5-94c7-441e-9d6d-2311048f021d&Preview=1 Date 12/28/2011 Company Name Vizify Mailing Address 2937A NE Glisan Street Portland, OR 97232 Company Description Vizify likes to build wonderful things. Based in Portland, OR, we’re currently participating in TechStars (Seattle) and the Portland Seed Fund and are working on an awesome new way to make a great first impression. … Continue reading “Vizify Garners $940,000 New Funding Round”
SpaceCurve Obtains $150,975 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=960303f3-de47-4894-a7c7-9e32f90f9699&Preview=1 Date 12/28/2011 Company Name SpaceCurve Mailing Address 1301 4Th Aveapt 902 Seattle, WA 98101 Company Description SpaceCurve is a fundamentally new kind of massively parallel analytical database technology. Effortlessly index geospatial polygon data in real-time using Internet-scale compute clusters. Efficiently analyze social and semantic graphs on massively parallel systems. Fuse complex … Continue reading “SpaceCurve Obtains $150,975 New Financing”
Bacteria to Do Our Bidding
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Broad claims covering delivery of therapeutics using engineered bacteria. Synthetic biology tools emerging in just the last few years have made this possible. The trick, of course, is precise control. If I … Continue reading “Bacteria to Do Our Bidding”
12 Big Questions for Seattle Tech in 2012
I don’t want to read too much into the arbitrary turn of the calendar, but it seems like we’re in the middle of a pretty interesting moment for Seattle’s technology scene. One of our mega-companies may be on the wane, while the other appears to be headed for much bigger things. The startup scene is … Continue reading “12 Big Questions for Seattle Tech in 2012”
Beyond the iPad to the hPad
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Two patents: a. A low-cost holographic pad: an “hPad,” which would sit on your desk and project three-dimensional fixed and moving images. It would include a touchscreen-like functionality. This would not only … Continue reading “Beyond the iPad to the hPad”
Seattle Rewind: AT&T-Mo, Google, Amazon, Angels & More
AT&T shook up a potentially drowsy holiday week with the news that it was abandoning its $39 billion bid for Bellevue, WA-based T-Mobile. Ma Bell and T-Mo’s parent, Deutsche Telekom, telegraphed the end of their deal a week earlier when they got a federal antitrust lawsuit suspended. It seemed for a while like maybe there … Continue reading “Seattle Rewind: AT&T-Mo, Google, Amazon, Angels & More”
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles
Seattle-based Allozyne wasn’t able to go public this year, so it has fallen back on Plan B, tapping its existing venture capital backers one more time in a bid to create more value around its lead multiple sclerosis drug candidate. Allozyne, which has spent about $50 million since its founding in 2005 and was down … Continue reading “Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles”
Beyond the Tablet Wars: Apple, Amazon, and the Cloud
Much has been written on the battle between Apple and Amazon. Certainly Steve Jobs’ passing has made us all reflect, and perhaps on a much deeper level than before, on the man and the empire he created. In many ways, the companies are more alike than they are different. What makes them both remarkable players … Continue reading “Beyond the Tablet Wars: Apple, Amazon, and the Cloud”
The Year in Seattle Medical Devices, Diagnostics, Health IT
Yesterday, we ran the first half of the Seattle life sciences year in review, which focused on biopharmaceutical companies and global health organizations. Today’s rundown will cover the medical device, diagnostic, and health IT side of the local life sciences cluster. Medical devices may not fare so well in a glamour contest, but this year … Continue reading “The Year in Seattle Medical Devices, Diagnostics, Health IT”
15 Great Apps for that iPad Under the Tree
The iPad 2 won’t be the only tablet turning up as a holiday gift this year: it’s finally got some real competition in the form of the more affordable Kindle Fire. But let’s face it: you don’t buy (or give someone) a Kindle Fire because of the apps. The device is designed primarily as a … Continue reading “15 Great Apps for that iPad Under the Tree”
Enabling the Cleantech Revolution
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] It is a very dynamic time for the emerging cleantech market, and success will only be ensured if strong technologies are combined in systems that work the first time. So, if I … Continue reading “Enabling the Cleantech Revolution”
24-Hour, Full-Genome Scans
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] A DNA sequencing technology that results in full genome scans in less than 24 hours. This would enable real-time profiling of cancer patients, which would be of tremendous value in determining the … Continue reading “24-Hour, Full-Genome Scans”
Allozyne Receives New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da419c99-6e8d-4779-95c1-f47d48cf6fb9&Preview=1 Date 12/23/2011 Company Name Allozyne Mailing Address 1600 Fairview Ave E Seattle, WA 98102 Company Description Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics. Website http://www.allozyne.com Transaction Type Venture … Continue reading “Allozyne Receives New Round”
Google’s New Seattle Director: Cloud Expert Doug Orr
Google’s new site director in Seattle is Doug Orr, a senior engineer at the tech giant who was working most recently on cloud computing projects, two sources tell Xconomy. Orr takes over for Brian Bershad, a former University of Washington professor who is now working for Google in Russia, one of our sources confirms. Word of Bershad’s … Continue reading “Google’s New Seattle Director: Cloud Expert Doug Orr”
Report: Amazon Opening Boston-Area Office
I guess Werner Vogels changed his mind. Amazon.com’s chief technology officer told me a couple years ago that his company had no intention of opening a Boston office. MIT engineers, he said, had no problem moving out west to Seattle to join the e-retail technology giant. I thought that was kind of strange, but Amazon … Continue reading “Report: Amazon Opening Boston-Area Office”
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy
Seattle-based Allozyne spent the last six months trying to go public by merging into the shell of what used to be an active, publicly traded biotech company. But in the end, the deal fell apart. Allozyne and San Francisco-based Poniard Pharmaceuticals (NASDAQ: [[ticker:PARD]]) said today in a statement they have “mutually agreed to terminate” the … Continue reading “Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy”
Innovation on Call: Insights from the Stratos Idea Factory
It’s been said plenty of times: If the U.S. wants to get out of this seemingly neverending economic malaise, we’ll have to innovate our way out. It’s a good idea, and a great slogan. But actually making it happen is not so easy. Sean MacLeod, president of Seattle’s Stratos Product Development, sees this kind of … Continue reading “Innovation on Call: Insights from the Stratos Idea Factory”